The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease

Brain Research

Volumn 749, Issue 1, 1997, Pages 170-174

  Faucheux, Baptiste A ^a   Hauw, Jean Jacques ^a   Agid, Yves ^a   Hirsch, Etienne C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Autoradiography; Cell death; Iron; Oxidative stress; Parkinson's disease; Substantia nigra; Transferrin receptor; Ventral tegmental area

Indexed keywords

MELANIN; RADIOLIGAND; TRANSFERRIN; TRANSFERRIN RECEPTOR; DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

AGED; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CASE REPORT; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM; MESENCEPHALON; METABOLISM; NERVE CELL; PATHOLOGY;

AGED; AGED, 80 AND OVER; AUTORADIOGRAPHY; BINDING SITES; HUMANS; IODINE RADIOISOTOPES; MESENCEPHALON; NEURONS; PARKINSON DISEASE; SUBSTANTIA NIGRA; TRANSFERRIN; VENTRAL TEGMENTAL AREA;

EID: 0030615199     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01412-6     Document Type: Article

References (22)

1. Aisen, P., Entry of iron into cells: a new role for the transferrin receptor in modulating iron release from transferrin, Ann. Neurol., 32 Suppl. (1992) S62-S68.
2. Aisen, P. and Leibman, A., Lactoferrin and transferrin: a comparative study, Biochim. Biophys. Acta, 257 (1972) 314-323.
3. Connor, J.R. and Menzies, S.L., Cellular management of iron in the brain, J. Neurol. Sci., 134 Suppl. (1995) 33-44.
4. Fahn, S. and Cohen, G., The oxidant stress hypothesis in Parkinson's disease. Evidence supporting it, Ann. Neurol., 32 (1992) 804-812.
5. Faucheux, B.A., Hirsch, E.C., Villares, J., Selimi, F., Mouatt-Prigent, A., Javoy-Agid, F., Hauw, J.-J. and Agid, Y., Distribution of 1251-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease, J. Neurochem., 60 (1993) 2338-2341.
6. Faucheux, B.A., Nillesse, N., Damier, P., Spik, G., Mouatt-Prigent, A., Pierce, A., Leveugle, B., Kubis, N., Hauw, J.-J., Agid, Y. and Hirsch, E.C., Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease, Proc. Natl. Acad. Sci. USA, 92 (1995) 9603-9607.
7. Fearnley, J.M. and Lees, A.J., Ageing and Parkinson's disease: substantia nigra regional selectivity, Brain, 114 (1991) 2283-2301.
8. Good, P.F., Olanow, C.W. and Perl, D.P., Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminium in Parkinson's disease: a LAMMA study, Brain Res., 593 (1992) 343-346.
9. Graeber, M.B., Raivich, G. and Kreutzberg, G.W., Increase of transferrin receptors and iron uptake in regenerating motor neurons, J. Neurosci. Res., 23 (1989) 342-345.
10. Graybiel, A.M. and Ragsdale, C.W., Histochemically distinct compartments in the striatum of human, monkey and cat demonstrated by acetylthiocholinesterase stain, Proc. Natl. Acad. Sci. USA, 75 (1978) 1723-1726.
11. Hirsch, E.C., Graybiel, A.M. and Agid, Y., Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature, 334 (1988) 345-348.
12. Hoehn, M.M. and Yahr, M.D., Parkinsonism: onset, progression and mortality. Neurology, 17 (1967) 427-442.
13. Javoy-Agid, F., Hirsch, E.C., Dumas, S., Duyckaerts, C., Mallet, J. and Agid, Y., Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study. Neuroscience, 38 (1990) 245-253.
14. Kalaria, R.N., Sromek, S.M., Grahovac, I. and Harik, S.I., Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease, Brain Res., 585 (1992) 87-93.
15. Kastner, A., Hirsch, E.C., Agid, Y. and Javoy-Agid, F., Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease, Brain Res., 606 (1993) 341-345.
16. Klausner, R.D., Rouault, T.A. and Harford, J.B., Regulating the fate of mRNA: the control of cellular iron metabolism, Cell, 72 (1993) 19-28.
17. Leveugle, B., Faucheux, B.A., Bouras, C., Nillesse, N., Spik, G., Hirsch, E.C., Agid, Y. and Hof, P.R., Immunohistochemical analysis of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases, Acta Neuropathol., 91 (1996) 566-572.
18. Mash, D.C., Pablo, J., Flynn, D.D., Efange, S.M.N. and Weiner, W.J., Characterization and distribution of transferrin receptors in the rat brain, J. Neurochem., 55 (1990) 1972-1979.
19. Morris, C.M., Candy, J.M., Omar, S., Bloxham, C.A. and Edwardson, J.A., Transferrin receptors in the Parkinsonian midbrain, Neuropathol. Appl. Neurobiol., 20 (1994) 468-472.
20. Riederer, P., Dirr, A., Goetz, M., Sofic, E., Jellinger, K. and Youdim, M.B.H., Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease, Ann. Neurol., 32 Suppl. (1992) S101-S104.
21. Sofic, E., Paulus, W., Jellinger, K., Riederer, P. and Youdim, M.B.H., Selective increase of iron in substantia nigra zona compacta of parkinsonian brains, J. Neurochem., 56 (1991) 978-982.
22. 2-microglobulin in the cerebrospinal fluid, Stroke, 12 (1981) 40-46.